Amedica Corporation, a spinal and orthopaedic implant company focused on silicon nitride ceramic technologies, announced today that Ben Shappley has joined the Company as its Chief Executive Officer and President. Mr. Shappley will also serve on the company’s Board of Directors.
Mr. Shappley has more than 25 years of orthopaedic and neurosurgical implant experience in both management and senior management roles. Most recently, he served as CEO and President of SpineMatrix. Prior to that, he was President of Theken Spine. Mr. Shappley has served in senior management positions in various companies including Therics Corporation, which was acquired by Theken Spine, Orthomatrix, Inc., Wright Medical Technology, Medtronic Sofamor Danek and Smith & Nephew. Mr. Shappley is a founding and charter member of the Institute for Orthopaedic Enlightenment and is a listed inventor on seven orthopaedic implant patents. Mr. Shappley holds a Bachelor of Science degree in Business Management.
“Our Board of Directors and Management team are pleased to extend a warm and enthusiastic welcome to Ben in his role at Amedica,” said Max Link, Ph.D., Chairman of Amedica Corporation. “We believe his extensive experience in the spine and orthopaedic industries will provide significant skills to grow our spinal and orthopaedic implant business.”
“It is my pleasure to welcome Ben to Amedica,” said Ashok C. Khandkar, Ph.D., Vice Chairman of Amedica Corporation. “With Ben joining our team and leading operations and commercialization efforts, our business and technical leadership will be better positioned for success in the years ahead. This will free me to concentrate my efforts to developing and expanding Amedica’s unique silicon nitride technology. I also look forward to devoting more time to broaden the portfolio of new and exciting products for the orthopaedic industry.”
“I am pleased to be a part of Amedica, its significant and important technologies and successful management team. I believe that Amedica’s advanced and heavily-patented silicon nitride ceramic technologies will play a continuing major role in cost-effective, improved spinal patient care,” said Mr. Shappley.
Source: Amedica Corp